Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
7Activity
0 of .
Results for:
No results containing your search query
P. 1
Botulinum toxin cosmetic therapy correlates with a more positive mood.

Botulinum toxin cosmetic therapy correlates with a more positive mood.

Ratings: (0)|Views: 2,217|Likes:
Published by lizardocd

More info:

Published by: lizardocd on Oct 30, 2009
Copyright:Traditional Copyright: All rights reserved

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

11/16/2014

pdf

text

original

 
 24
 © 2009 Wiley Periodicals, Inc.
  Journal of Cosmetic Dermatology 
 ,
8
 , 24–26
 Original Contribution
 BlackwellPublishingInc
 ORIGINAL CONTRIBUTION
 Botulinum toxin cosmetic therapy correlates with a morepositive mood
 Michael B Lewis, PhD
 1
 & Patrick J Bowler, MB, BS
 2
 
1
 School of Psychology, Cardiff University, Cardiff, UK 
 
2
 Court House Clinics, London, UK 
 
Summary
 
Background 
 
It has been suggested that botulinum toxin A (BTX-A) treatment for frownlines can also be used as a treatment for depression. A psychological mechanism for thiseffect is reviewed in which paralysis of the corrugator (frown) muscles leads to less facialfeedback for negative emotions. Consequently, a negative affect is harder to maintain andso the person has a more positive mood.
 
Methods
 
In order to test this mechanism, the mood of patients who had received BTX-Atreatment for glabelar frown lines was measured and compared with patients who hadreceived other cosmetic treatments.
 
Results
 
The BTX-A–treated patients showed significantly less negative mood.
 
Conclusion
 
The results support the facial feedback view that frowning can make oneunhappier. Treatments that prevent frowning correlate with reduced negative mood.
 
Keywords
 
:
 
botulinum toxin A, glabelar frown lines, mood, depression, facial feedback
 
Introduction
 
Facial muscles do not just express emotions but they arealso involved in the experience or feeling of emotions:Smiling while reading a cartoon, for example, increasesamusement.
 
1
 
This feedback loop between the expressionof and experience of emotions was suggested by CharlesDarwin and there is now an accumulation of evidenceillustrating how facial-muscular action can affect ourmood and perception.
 
2
 
Failure to produce emotional expression also affectsmood: Patients with facial paralysis show symptoms of depression.
 
3
 
The severity of such patients’ depressivesymptoms has been found to correlated with the degreeto which their ability to smile was impaired.
 
4
 
Patientsunable to smile suffer from more depression. It is arguedthat the lack of positive facial feedback received from theabsent smile means that a positive mood is harder tomaintain.Localized facial muscular paralysis is a consequence of the use of botulinum toxin A (BTX-A; e.g. Botox® orDysport®) for cosmetic dermatology. One treatmentfor glabellar frown lines involves injections into thecorrugator (frown) muscles, paralyzing them for up to 6months. The cosmetic effect of this treatment is asmoother, less-lined forehead.
 
5
 
As well as being responsible for frown lines, the corruga-tor muscles are universally important in the expression of negative emotions including sadness, fear, anger anddistress.
 
6
 
The paralysis of these muscles means that theability to form facial expressions of these emotions isreduced. Indeed, it has been demonstrated that peoplewho have received BTX-A treatment for frown lines arerated as showing less negative facial expressions.
 
7
 
The facial feedback effect suggests that the paralysis of muscles associated with negative emotions may haveeffects beyond the outward appearance of emotion;
 Correspondence: Michael B Lewis, PhD, School of Psychology, CardiffUniversity, Park Place, Cardiff CF10 3AT, UK. E-mail: LewisMB@cf.ac.uk
  Accepted for publication October 2, 2008
 
 Botulinum toxin therapy and mood
 M B Lewis & P J Bowler 
 © 2009 Wiley Periodicals, Inc.
  Journal of Cosmetic Dermatology 
 ,
8
 , 24–26
 25
 
Paralysis of the frown muscles could make it harder tomaintain negative emotions just as paralysis of smilemuscles makes happy emotions harder to maintain.Some support for this comes from a study that suggeststhat BTX-A injections into the corrugator frown musclescould be used as a treatment for depression.
 
8
 
Ten patientswith depression were treated with BTX-A and it wasfound that there was a marked reduction in negativeaffect to a degree where nine of the patients no longershowed depressive symptoms. There were many limitationsto this initial study, such as a lack of a control group orlong-term follow-up, but the size of the observed effectmeans that it is worthy of further research. The treatmentwas based on theoretical grounds, but there is alsoanecdotal evidence of a general improvement in themood of patients having received BTX-A therapy.
 
9
 
Thismood effect may help to explain why BTX-A treatmentleads to higher satisfaction ratings than other forms of cosmetic treatments.
 
10
 
If BTX-A treatment does have a large effect on moodthen it should be apparent in patients who have electedfor the treatment for cosmetic reasons. The currentexperiment evaluated this by testing the mood of patientswho had received BTX-A therapy for glabellar frown linesand comparing these with patients who had other formsof cosmetic treatment. It was hypothesized that patientswho had received the BTX-A treatment to the foreheadwould show a more positive mood than patients who hadreceived other forms of cosmetic therapy.
 
Method
 
Participants
 
Twenty-five participants took part (all white females).The participants were recruited through the Court HouseClinics and had all undergone some form of aestheticcosmetic treatment in the previous 7 days to 3 months.Many of these patients had received a variety of treatments,but they were categorized as either having had BTX-Atreatment to the forehead or not. Those not havingBTX-A treatment to the forehead may have had BTX-Aelsewhere (e.g. as a treatment for crows feet), but theywere still classified as the control group as it was nothypothesized that this treatment would affect mood. Theother treatments that the participants reported receivingincluded: glycolic peels, laser treatments, and Restylane.Twelve of the participants had undergone BTX-Atherapy to the forehead (including treatment for glabelarfrown lines) as well as, in several cases, some othertherapies. This group was designated as the BTX-A-treatedgroup and had a mean age of 47 years (SD = 9.2). Theremaining 13 participants had received cosmetic therapiesother than BTX-A to the forehead. This group wasdesignated as the control group and had a mean age of 44 years (SD = 16.0).
 
Procedure
 
Participants were given a questionnaire to fill in andreturn anonymously to Cardiff University, School of Psychology. This questionnaire asked for demographicdetails and for details of any cosmetic treatment they hadreceived recently and historically. The questionnaire alsoincluded a copy of the Irritability-Depression-AnxietyScale (IDAS).
 
11
 
This questionnaire consists of 14 questionswith four choices of answers. It provides three measures of mood based on three distinguishable elements (irritability,depression, and anxiety). The questionnaire also askedparticipants to provide a percentage value measure of their attractiveness now and prior to the treatment theyhad just received.
 
Results
 
The attractiveness ratings of the two sets of participantswere greater after treatment (both being 52 on a 100-point scale) than before treatment. The size of the change,however, was small: BTX-A–treated group increased by 6points (
 
 
= 9;
SD
 
= 10.0), whereas the control groupincreased by 3 points (
 
 
= 10;
SD
 
= 6.5). This differencedid not reach significance [
 
t
 
(17) = 1.143;
P
 
= 0.269].The means from the three values on the IDAS measurefor the two groups are shown in Fig. 1. These data indicate
Figure 1
Individual and average scores from the three measuresproduced by the IDAS questionnaire split according to whetherparticipants had received BTX-A treatment or not. Error barsrepresent 95% confidence intervals. The dotted lines represent theboundary between normal scores (below the dotted line) andborderline morbid scores (above the dotted line) for the IDASquestionnaire.

Activity (7)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
salmanfrs liked this
Jake Sloane liked this

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->